ARTICLE
15 August 2025

Notable Ruling Roundup

PC
Perkins Coie LLP

Contributor

Perkins Coie is a premier international law firm with over a century of experience, dedicated to addressing the legal and business challenges of tomorrow. Renowned for its deep industry knowledge and client-centric approach, the firm has consistently partnered with trailblazing organizations, from aviation pioneers to artificial intelligence innovators. With 21 offices across the United States, Asia, and Europe, and a global network of partner firms, Perkins Coie provides seamless support to clients wherever they operate.

The firm's vision is to be the trusted advisor to the world’s most innovative companies, delivering strategic, high-value solutions critical to their success. Guided by a one-firm culture, Perkins Coie emphasizes excellence, collaboration, inclusion, innovation, and creativity. The firm is committed to building diverse teams, promoting equal access to justice, and upholding the rule of law, reflecting its core values and enduring dedication to clients, communities, and colleagues.

Our notable ruling roundup aims to keep our readers up to date on recent rulings in the food & consumer packaged goods space.
United States California Food, Drugs, Healthcare, Life Sciences

Our notable ruling roundup aims to keep our readers up to date on recent rulings in the food & consumer packaged goods space.

Kimberly Banks, et al. v. R.C. Bigelow, Inc., No.2:20-cv-06208-DDP-RAO (C.D. Cal. – April 8, 2025): A California federal jury found defendant committed fraud and violated California's Consumers Legal Remedies Act by labeling its tea products as "Manufactured in the USA," awarding $2.36 million in damages. Plaintiffs filed the suit in 2020, alleging defendant labeled their tea products as "Manufactured in the USA," despite the majority of the tea leaves being sourced from overseas, including countries such as China and Sri Lanka. Opinion available here.

California Chamber of Commerce v. Rob Bonta, et al., No. 2:19-cv-02019-DJC-JDP (E.D. Cal. – May 2, 2025): The U.S. District Court for the Eastern District of California granted summary judgment and issued a permanent injunction in the plaintiff's favor in a suit challenging Prop. 65's requirement that companies warn buyers about dietary acrylamide in their products. Plaintiff argued that the warnings were misleading and violated the First Amendment by compelling businesses to convey a message that dietary acrylamide causes cancer, despite a lack of scientific consensus. The court agreed and concluded that the warnings were not "purely factual and uncontroversial" because they conveyed a one-sided view that dietary acrylamide poses a human cancer risk without sufficient scientific consensus. As a result, the court issued a permanent injunction preventing the enforcement of Prop. 65's warning requirements for dietary acrylamide and declared the warning requirements unconstitutional as applied to dietary acrylamide. Opinion available here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More